Cell Line Development Market
Cell Line Development Market Analysis by Immunotherapy Cell Lines, Ion Channel Cell Lines, and GPCR Cell Lines from 2023 to 2033
Analysis of Cell Line Development Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cell Line Development Market Outlook (2023 to 2033)
The value of the global cell line development market stands at US$ 4.97 billion in 2023 and is projected to reach a valuation of US$ 8.2 billion by the end of 2033. Over the next ten years, Fact.MR’s research projects global demand for cell line development to rise at 5.1% CAGR.
Rising demand for cell line development around the world can be primarily ascribed to the high prevalence of chronic disorders and ever-increasing research activities in the medical industry. Growing adoption of cell lines in several medical research applications and rising demand for novel drug discovery procedures are also expected to drive the demand for cell line development services in the future.
- In May 2021, Eyestem, a company focusing on providing affordable cell therapies, announced that it had raised funding from Endiya Partners, a leading venture capital firm in India. Eyestem had plans to use the capital to advance its research and scale its business to provide affordable cell therapies for the Indian people.
Surging use of human cells in clinical research owing to their ability to produce human proteins that bear post-translational modifications (PTMs) are also projected to positively impact market growth going forward. Advancements in cell research and growing demand for cell therapies are also expected to uplift sales of cell line development products over the coming years.
Recombinant cell lines, mammalian cell lines, animal cell lines, and stem cell lines are expected to witness a notable hike in demand as well as popularity across the forecast period and beyond. Increasing awareness regarding the efficacy and benefits of regenerative medicine around the world is slated to fuel research and redefine the limits of the cell line development industry through 2033.
On the flip side, unclear regulatory guidelines and lack of awareness regarding cell lines and cell line development around the world are anticipated to be major constraints for market evolution in the long run. High chances of contamination and high initial costs for laboratory set-ups are also expected to be major challenges for cell line development companies over the next ten years and beyond.
| Report Attributes | Details |
|---|---|
| Cell Line Development Market Size (2023) | US$ 4.97 Billion |
| Projected Market Value (2033F) | US$ 8.2 Billion |
| Global Market Growth Rate (2023 to 2033) | 5.1% CAGR |
| Market Share of Biopharmaceutical Companies (2033F) | >35% |
| Market Share of the United States in North America (2023) | >90% |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; WuXi AppTec Co. Ltd.; Corning Incorporated; Selexis SA; Sigma-Aldrich Corporation; Sartorius AG; General Electric Company; Lonza Group Ltd.; Abzena plc.; American Type Culture Collection Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How Can New Companies Push the Boundaries of Cell Line Development?
“Unlocking Full Potential of Cells - Key to Pushing Limits of Growth Potential”
All types of human cells have the genetic information necessary to become any specific kind of cell, which means there is still a lot of potential in cell therapy that is yet to be unlocked. Incoming cell line development companies are investing heavily in research to come up with novel products and solutions that could transform our understanding of the importance of cells in the healthcare industry.
- A United Kingdom-based startup called bit.bio founded in 2016, is focusing on revolutionizing drug discovery and clinical research by utilizing precisely engineered human cells. The company currently offers muscle cell lines that have been reprogrammed to create genetic modifications and help in different healthcare research and drug discovery applications.
- Asimov, a synthetic biology company founded in 2017, raised US$ 175 billion in a Series B funding round led that was led by the Canada Pension Plan Investment Board (CPP Investments) in January 2023. The company is building tools to program living cells by combining mammalian synthetic biology with advanced computer-aided design technologies.
Lab-grown meat and cell culture meat has been gaining popularity in recent years and this is where animal cells are anticipated to witness a hike in demand going forward. Cell line development start-ups are coming up with unique solutions to prepare cultured meat using animal cells.
- A Korean start-up called CellQua, specializing in aquaculture cultured meat, announced that it had raised a seed investment in April 2023, from Sopoong Ventures, an impact investor. The company was expected to use cells from aquatic animals such as eels, squids, and loaches to develop cultured meat.
- In October 2022, TissenBioFarm, a new company focusing on sustainable food production, announced that it had raised around US$ 1.6 billion in a pre-Series A financing round led by Envisioning Partners. The company uses living animal cells and functional bio-ink to create cultured meat.
An exhaustive analysis of how aspects such as new developments, supply chain management, product standards, pricing trends, and safety regulations are affected by start-ups has been extensively discussed in this latest cell line development market research study by analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
Which are the Most Appealing Markets for Cell Line Development in APAC?
“China, South Korea, Japan – Leading Asian Markets”
Increasing investments in healthcare infrastructure development in Asian countries is a prominent factor that is projected to uplift the demand for cell line development in the Asia Pacific region over the coming years. The surging popularity of stem cell therapies, growing demand for regenerative medicine, and high investments in medical research are other prospects that create moneymaking opportunities for cell line development companies in APAC.
Supportive government initiatives to promote healthcare infrastructure development in China, Japan, and South Korea are expected to primarily bolster demand for cell line development services across the forecast period. Induced pluripotent stem cells (iPSCs), isogeneic cell lines, epidermal cell sheets, and stable cell lines are projected to have a bright demand outlook in the aforementioned Asian countries through 2033.
What’s Attracting Cell Line Development Providers to Europe?
“Continuously Rising Demand for Regenerative Medicine”
Regenerative therapies and treatments have witnessed a notable hike in popularity in the European region in recent years, which has subsequently favored demand for regenerative medicines. Increasing investments in healthcare infrastructure development and rising healthcare research activity in European countries are also projected to uplift sales of cell line development tools and products in the future.
Increasing acceptance and awareness regarding stem cell therapies and notable advancements in the fields of nano healthcare technology, chemical biology, genetic engineering, etc. are also projected to further promulgate cell line development demand in the European region going forward. France, Spain, and the United Kingdom are anticipated to emerge as highly rewarding markets in this region in the long run.
On the contrary, restrictions regarding stem cell research in certain European countries such as Germany and Italy are expected to hinder market growth in the European region throughout the forecast period.
Why is the United States a Crucial Market in This Space?
“High Spending on Medical Research and Presence of Key Biopharmaceutical Companies”
The United States is estimated to emerge as one of the most captivating marketplaces for cell line development in the world and this is why it is projected to offer highly remunerative business opportunities for cell line development providers as well. Rising investments in medical R&D from the public and private sectors is an elemental aspect that is slated to foster market growth in the country over the next ten years.
The presence of key biopharmaceutical companies, surging demand for cell therapies, quick adoption of novel cell line development approaches, and the surging popularity of automated cell line development are other factors that are projected to sculpt market development across the forecast period. High incidence of cancer and rising demand for cell therapies to treat the same are also expected to boost cell line development demand in the United States over the coming years.
- At present, demand for cell line development in the United States accounts for more than 90% share of the North American regional market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Where Will Demand for Cell Line Development Soar High?
“Biopharmaceutical Companies to Spearhead Market Development”
Based on end user, the market for cell line development is segmented into contract research organizations (CROs), forensic science laboratories, biopharmaceutical companies, food & beverage companies, academic & research institutes, diagnostic centers, and others.
Surging demand for new medications and antibiotics owing to the growing prevalence of chronic diseases around the world is anticipated to be a prime factor driving cell line development demand in biopharmaceutical companies over the coming years. High investments in medical research and increasing demand for novel healthcare products are also expected to benefit the demand outlook in biopharmaceutical organizations in the future.
- By the end of the forecast period, biopharmaceutical companies are estimated to account for nearly 35% of the global market share.
Healthcare contract research organizations and academic research institutes are also anticipated to witness a notable surge in demand for cell line development across the forecast period as focus on research bolsters around the world.
Competitive Landscape:
Leading cell line development providers are focusing on research and development of unique approaches that could aid in the creation of better and more effective cell therapies to treat various diseases.
- In January 2023, Berkeley Lights Inc., a leading life sciences tools provider, announced the launch of a new optofluidic system for cell line development. The Beacon Select™ system is based on the same technology that its predecessor was launched with back in 2017.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Cell Line Development Industry Research
-
By Product Type :
- Immunotherapy Cell Lines
- Ion Channel Cell Lines
- GPCR Cell Lines
- Cell Signaling Pathway Cell Lines
- Gene Knockout Cell Lines
- Cancer Cell Lines
- Other
-
By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
-
By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By Product Type
- 3.1. Immunotherapy
- 3.2. Ion Channel
- 3.3. GPCR
- 3.4. Cell Signaling Pathway
- 3.5. Gene Knockout
- 3.6. Cancer
- 3.7. Other
- 4. Global Market Analysis and Forecast By End User
- 4.1. Biopharmaceutical Companies
- 4.2. Contract Research Organizations (CROs)
- 4.3. Academic & Research Institutes
- 4.4. Forensic Science Laboratories
- 4.5. Food & Beverage Companies
- 4.6. Diagnostic Centers
- 4.7. Others
- 5. Global Market Analysis and Forecast By Application
- 5.1. Drug Discovery & Development
- 5.2. Basic Research
- 5.3. Toxicity Screening
- 5.4. Biopharmaceutical Production
- 5.5. Drug Screening
- 5.6. Tissue Engineering
- 5.7. Forensic Testing
- 6. Global Market Analysis and Forecast By Region
- 6.1. North America
- 6.2. Latin America
- 6.3. Europe
- 6.4. Japan
- 6.5. APEJ
- 6.6. MEA
- 7. North America Market Analysis and Forecast, By Country, 2018 to 2033
- 8. Latin America Market Analysis and Forecast, By Country, 2018 to 2033
- 9. Europe Market Analysis and Forecast, By Country, 2018 to 2033
- 10. Japan Market Analysis and Forecast, By Country, 2018 to 2033
- 11. APEJ Market Analysis and Forecast, By Country, 2018 to 2033
- 12. MEA Market Analysis and Forecast, By Country, 2018 to 2033
- 13. Global Market Competition Landscape and Company Profile
- 13.1. Thermo Fisher Scientific, Inc
- 13.2. American Type Culture Collection Inc
- 13.3. Corning Incorporated
- 13.4. Lonza Group Ltd
- 13.5. Sartorius AG
- 13.6. Selexis SA
- 13.7. WuXi AppTec Co., Ltd.
- 13.8. Sigma-Aldrich Corporation
- 13.9. General Electric Company
- 13.10. Abzena plc
- 14. Research Methodology
- 15. Secondary and Primary Sources
- 16. Assumptions and Acronyms
- 17. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2018 to 2022
TABLE 02: Global Market Value (US$ Mn), 2023 to 2033
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2033
TABLE 04: Global Immunotherapy Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 05: Global Immunotherapy Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 06: Global Immunotherapy Segment Market Share, By Region 2018 to 2022
TABLE 07: Global Immunotherapy Segment Market Share, By Region 2023 to 2033
TABLE 08: Global Immunotherapy Segment Y-o-Y, By Region 2015 to 2033
TABLE 09: Global Ion Channel Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 10: Global Ion Channel Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 11: Global Ion Channel Segment Market Share, By Region 2018 to 2022
TABLE 12: Global Ion Channel Segment Market Share, By Region 2023 to 2033
TABLE 13: Global Ion Channel Segment Y-o-Y, By Region 2015 to 2033
TABLE 14: Global GPCR Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 15: Global GPCR Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 16: Global GPCR Segment Market Share, By Region 2018 to 2022
TABLE 17: Global GPCR Segment Market Share, By Region 2023 to 2033
TABLE 18: Global GPCR Segment Y-o-Y, By Region 2015 to 2033
TABLE 19: Global Cell Signaling Pathway Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 20: Global Cell Signaling Pathway Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 21: Global Cell Signaling Pathway Segment Market Share, By Region 2018 to 2022
TABLE 22: Global Cell Signaling Pathway Segment Market Share, By Region 2023 to 2033
TABLE 23: Global Cell Signaling Pathway Segment Y-o-Y, By Region 2015 to 2033
TABLE 24: Global Gene Knockout Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 25: Global Gene Knockout Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 26: Global Gene Knockout Segment Market Share, By Region 2018 to 2022
TABLE 27: Global Gene Knockout Segment Market Share, By Region 2023 to 2033
TABLE 28: Global Gene Knockout Segment Y-o-Y, By Region 2015 to 2033
TABLE 29: Global Cancer Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 30: Global Cancer Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 31: Global Cancer Segment Market Share, By Region 2018 to 2022
TABLE 32: Global Cancer Segment Market Share, By Region 2023 to 2033
TABLE 33: Global Cancer Segment Y-o-Y, By Region 2015 to 2033
TABLE 34: Global Other Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 35: Global Other Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 36: Global Other Segment Market Share, By Region 2018 to 2022
TABLE 37: Global Other Segment Market Share, By Region 2023 to 2033
TABLE 38: Global Other Segment Y-o-Y, By Region 2015 to 2033
TABLE 39: Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 40: Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 41: Global Biopharmaceutical Companies Segment Market Share, By Region 2018 to 2022
TABLE 42: Global Biopharmaceutical Companies Segment Market Share, By Region 2023 to 2033
TABLE 43: Global Biopharmaceutical Companies Segment Y-o-Y, By Region 2015 to 2033
TABLE 44: Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 45: Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 46: Global Contract Research Organizations (CROs) Segment Market Share, By Region 2018 to 2022
TABLE 47: Global Contract Research Organizations (CROs) Segment Market Share, By Region 2023 to 2033
TABLE 48: Global Contract Research Organizations (CROs) Segment Y-o-Y, By Region 2015 to 2033
TABLE 49: Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 50: Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 51: Global Academic & Research Institutes Segment Market Share, By Region 2018 to 2022
TABLE 52: Global Academic & Research Institutes Segment Market Share, By Region 2023 to 2033
TABLE 53: Global Academic & Research Institutes Segment Y-o-Y, By Region 2015 to 2033
TABLE 54: Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 55: Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 56: Global Forensic Science Laboratories Segment Market Share, By Region 2018 to 2022
TABLE 57: Global Forensic Science Laboratories Segment Market Share, By Region 2023 to 2033
TABLE 58: Global Forensic Science Laboratories Segment Y-o-Y, By Region 2015 to 2033
TABLE 59: Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 60: Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 61: Global Food & Beverage Companies Segment Market Share, By Region 2018 to 2022
TABLE 62: Global Food & Beverage Companies Segment Market Share, By Region 2023 to 2033
TABLE 63: Global Food & Beverage Companies Segment Y-o-Y, By Region 2015 to 2033
TABLE 64: Global Diagnostic Centers Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 65: Global Diagnostic Centers Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 66: Global Diagnostic Centers Segment Market Share, By Region 2018 to 2022
TABLE 67: Global Diagnostic Centers Segment Market Share, By Region 2023 to 2033
TABLE 68: Global Diagnostic Centers Segment Y-o-Y, By Region 2015 to 2033
TABLE 69: Global Others Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 70: Global Others Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 71: Global Others Segment Market Share, By Region 2018 to 2022
TABLE 72: Global Others Segment Market Share, By Region 2023 to 2033
TABLE 73: Global Others Segment Y-o-Y, By Region 2015 to 2033
TABLE 74: Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 75: Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 76: Global Drug Discovery & Development Segment Market Share, By Region 2018 to 2022
TABLE 77: Global Drug Discovery & Development Segment Market Share, By Region 2023 to 2033
TABLE 78: Global Drug Discovery & Development Segment Y-o-Y, By Region 2015 to 2033
TABLE 79: Global Basic Research Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 80: Global Basic Research Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 81: Global Basic Research Segment Market Share, By Region 2018 to 2022
TABLE 82: Global Basic Research Segment Market Share, By Region 2023 to 2033
TABLE 83: Global Basic Research Segment Y-o-Y, By Region 2015 to 2033
TABLE 84: Global Toxicity Screening Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 85: Global Toxicity Screening Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 86: Global Toxicity Screening Segment Market Share, By Region 2018 to 2022
TABLE 87: Global Toxicity Screening Segment Market Share, By Region 2023 to 2033
TABLE 88: Global Toxicity Screening Segment Y-o-Y, By Region 2015 to 2033
TABLE 89: Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 90: Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 91: Global Biopharmaceutical Production Segment Market Share, By Region 2018 to 2022
TABLE 92: Global Biopharmaceutical Production Segment Market Share, By Region 2023 to 2033
TABLE 93: Global Biopharmaceutical Production Segment Y-o-Y, By Region 2015 to 2033
TABLE 94: Global Drug Screening Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 95: Global Drug Screening Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 96: Global Drug Screening Segment Market Share, By Region 2018 to 2022
TABLE 97: Global Drug Screening Segment Market Share, By Region 2023 to 2033
TABLE 98: Global Drug Screening Segment Y-o-Y, By Region 2015 to 2033
TABLE 99: Global Tissue Engineering Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 100: Global Tissue Engineering Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 101: Global Tissue Engineering Segment Market Share, By Region 2018 to 2022
TABLE 102: Global Tissue Engineering Segment Market Share, By Region 2023 to 2033
TABLE 103: Global Tissue Engineering Segment Y-o-Y, By Region 2015 to 2033
TABLE 104: Global Forensic Testing Segment Value (US$ Mn), By Region 2018 to 2022
TABLE 105: Global Forensic Testing Segment Value (US$ Mn), By Region 2023 to 2033
TABLE 106: Global Forensic Testing Segment Market Share, By Region 2018 to 2022
TABLE 107: Global Forensic Testing Segment Market Share, By Region 2023 to 2033
TABLE 108: Global Forensic Testing Segment Y-o-Y, By Region 2015 to 2033
TABLE 109: North America Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 110: North America Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 111: North America Market Value (US$ Mn), By End User 2018 to 2022
TABLE 112: North America Market Value (US$ Mn), By End User 2023 to 2033
TABLE 113: North America Market Value (US$ Mn), By Application 2018 to 2022
TABLE 114: North America Market Value (US$ Mn), By Application 2023 to 2033
TABLE 115: Latin America Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 116: Latin America Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 117: Latin America Market Value (US$ Mn), By End User 2018 to 2022
TABLE 118: Latin America Market Value (US$ Mn), By End User 2023 to 2033
TABLE 119: Latin America Market Value (US$ Mn), By Application 2018 to 2022
TABLE 120: Latin America Market Value (US$ Mn), By Application 2023 to 2033
TABLE 121: Europe Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 122: Europe Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 123: Europe Market Value (US$ Mn), By End User 2018 to 2022
TABLE 124: Europe Market Value (US$ Mn), By End User 2023 to 2033
TABLE 125: Europe Market Value (US$ Mn), By Application 2018 to 2022
TABLE 126: Europe Market Value (US$ Mn), By Application 2023 to 2033
TABLE 127: Japan Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 128: Japan Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 129: Japan Market Value (US$ Mn), By End User 2018 to 2022
TABLE 130: Japan Market Value (US$ Mn), By End User 2023 to 2033
TABLE 131: Japan Market Value (US$ Mn), By Application 2018 to 2022
TABLE 132: Japan Market Value (US$ Mn), By Application 2023 to 2033
TABLE 133: APEJ Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 134: APEJ Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 135: APEJ Market Value (US$ Mn), By End User 2018 to 2022
TABLE 136: APEJ Market Value (US$ Mn), By End User 2023 to 2033
TABLE 137: APEJ Market Value (US$ Mn), By Application 2018 to 2022
TABLE 138: APEJ Market Value (US$ Mn), By Application 2023 to 2033
TABLE 139: MEA Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 140: MEA Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 141: MEA Market Value (US$ Mn), By End User 2018 to 2022
TABLE 142: MEA Market Value (US$ Mn), By End User 2023 to 2033
TABLE 143: MEA Market Value (US$ Mn), By Application 2018 to 2022
TABLE 144: MEA Market Value (US$ Mn), By Application 2023 to 2033
TABLE 145: US Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 146: US Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 147: US Market Value (US$ Mn), By End User 2018 to 2022
TABLE 148: US Market Value (US$ Mn), By End User 2023 to 2033
TABLE 149: US Market Value (US$ Mn), By Application 2018 to 2022
TABLE 150: US Market Value (US$ Mn), By Application 2023 to 2033
TABLE 151: Canada Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 152: Canada Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 153: Canada Market Value (US$ Mn), By End User 2018 to 2022
TABLE 154: Canada Market Value (US$ Mn), By End User 2023 to 2033
TABLE 155: Canada Market Value (US$ Mn), By Application 2018 to 2022
TABLE 156: Canada Market Value (US$ Mn), By Application 2023 to 2033
TABLE 157: Brazil Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 158: Brazil Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 159: Brazil Market Value (US$ Mn), By End User 2018 to 2022
TABLE 160: Brazil Market Value (US$ Mn), By End User 2023 to 2033
TABLE 161: Brazil Market Value (US$ Mn), By Application 2018 to 2022
TABLE 162: Brazil Market Value (US$ Mn), By Application 2023 to 2033
TABLE 163: Mexico Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 164: Mexico Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 165: Mexico Market Value (US$ Mn), By End User 2018 to 2022
TABLE 166: Mexico Market Value (US$ Mn), By End User 2023 to 2033
TABLE 167: Mexico Market Value (US$ Mn), By Application 2018 to 2022
TABLE 168: Mexico Market Value (US$ Mn), By Application 2023 to 2033
TABLE 169: Argentina Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 170: Argentina Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 171: Argentina Market Value (US$ Mn), By End User 2018 to 2022
TABLE 172: Argentina Market Value (US$ Mn), By End User 2023 to 2033
TABLE 173: Argentina Market Value (US$ Mn), By Application 2018 to 2022
TABLE 174: Argentina Market Value (US$ Mn), By Application 2023 to 2033
TABLE 175: Germany Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 176: Germany Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 177: Germany Market Value (US$ Mn), By End User 2018 to 2022
TABLE 178: Germany Market Value (US$ Mn), By End User 2023 to 2033
TABLE 179: Germany Market Value (US$ Mn), By Application 2018 to 2022
TABLE 180: Germany Market Value (US$ Mn), By Application 2023 to 2033
TABLE 181: UK Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 182: UK Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 183: UK Market Value (US$ Mn), By End User 2018 to 2022
TABLE 184: UK Market Value (US$ Mn), By End User 2023 to 2033
TABLE 185: UK Market Value (US$ Mn), By Application 2018 to 2022
TABLE 186: UK Market Value (US$ Mn), By Application 2023 to 2033
TABLE 187: France Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 188: France Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 189: France Market Value (US$ Mn), By End User 2018 to 2022
TABLE 190: France Market Value (US$ Mn), By End User 2023 to 2033
TABLE 191: France Market Value (US$ Mn), By Application 2018 to 2022
TABLE 192: France Market Value (US$ Mn), By Application 2023 to 2033
TABLE 193: Spain Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 194: Spain Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 195: Spain Market Value (US$ Mn), By End User 2018 to 2022
TABLE 196: Spain Market Value (US$ Mn), By End User 2023 to 2033
TABLE 197: Spain Market Value (US$ Mn), By Application 2018 to 2022
TABLE 198: Spain Market Value (US$ Mn), By Application 2023 to 2033
TABLE 199: Italy Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 200: Italy Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 201: Italy Market Value (US$ Mn), By End User 2018 to 2022
TABLE 202: Italy Market Value (US$ Mn), By End User 2023 to 2033
TABLE 203: Italy Market Value (US$ Mn), By Application 2018 to 2022
TABLE 204: Italy Market Value (US$ Mn), By Application 2023 to 2033
TABLE 205: Nordic Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 206: Nordic Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 207: Nordic Market Value (US$ Mn), By End User 2018 to 2022
TABLE 208: Nordic Market Value (US$ Mn), By End User 2023 to 2033
TABLE 209: Nordic Market Value (US$ Mn), By Application 2018 to 2022
TABLE 210: Nordic Market Value (US$ Mn), By Application 2023 to 2033
TABLE 211: Japan Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 212: Japan Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 213: Japan Market Value (US$ Mn), By End User 2018 to 2022
TABLE 214: Japan Market Value (US$ Mn), By End User 2023 to 2033
TABLE 215: Japan Market Value (US$ Mn), By Application 2018 to 2022
TABLE 216: Japan Market Value (US$ Mn), By Application 2023 to 2033
TABLE 217: China Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 218: China Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 219: China Market Value (US$ Mn), By End User 2018 to 2022
TABLE 220: China Market Value (US$ Mn), By End User 2023 to 2033
TABLE 221: China Market Value (US$ Mn), By Application 2018 to 2022
TABLE 222: China Market Value (US$ Mn), By Application 2023 to 2033
TABLE 223: India Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 224: India Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 225: India Market Value (US$ Mn), By End User 2018 to 2022
TABLE 226: India Market Value (US$ Mn), By End User 2023 to 2033
TABLE 227: India Market Value (US$ Mn), By Application 2018 to 2022
TABLE 228: India Market Value (US$ Mn), By Application 2023 to 2033
TABLE 229: Malaysia Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 230: Malaysia Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 231: Malaysia Market Value (US$ Mn), By End User 2018 to 2022
TABLE 232: Malaysia Market Value (US$ Mn), By End User 2023 to 2033
TABLE 233: Malaysia Market Value (US$ Mn), By Application 2018 to 2022
TABLE 234: Malaysia Market Value (US$ Mn), By Application 2023 to 2033
TABLE 235: Thailand Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 236: Thailand Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 237: Thailand Market Value (US$ Mn), By End User 2018 to 2022
TABLE 238: Thailand Market Value (US$ Mn), By End User 2023 to 2033
TABLE 239: Thailand Market Value (US$ Mn), By Application 2018 to 2022
TABLE 240: Thailand Market Value (US$ Mn), By Application 2023 to 2033
TABLE 241: Singapore Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 242: Singapore Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 243: Singapore Market Value (US$ Mn), By End User 2018 to 2022
TABLE 244: Singapore Market Value (US$ Mn), By End User 2023 to 2033
TABLE 245: Singapore Market Value (US$ Mn), By Application 2018 to 2022
TABLE 246: Singapore Market Value (US$ Mn), By Application 2023 to 2033
TABLE 247: Australia Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 248: Australia Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 249: Australia Market Value (US$ Mn), By End User 2018 to 2022
TABLE 250: Australia Market Value (US$ Mn), By End User 2023 to 2033
TABLE 251: Australia Market Value (US$ Mn), By Application 2018 to 2022
TABLE 252: Australia Market Value (US$ Mn), By Application 2023 to 2033
TABLE 253: GCC Countries Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 254: GCC Countries Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 255: GCC Countries Market Value (US$ Mn), By End User 2018 to 2022
TABLE 256: GCC Countries Market Value (US$ Mn), By End User 2023 to 2033
TABLE 257: GCC Countries Market Value (US$ Mn), By Application 2018 to 2022
TABLE 258: GCC Countries Market Value (US$ Mn), By Application 2023 to 2033
TABLE 259: South Africa Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 260: South Africa Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 261: South Africa Market Value (US$ Mn), By End User 2018 to 2022
TABLE 262: South Africa Market Value (US$ Mn), By End User 2023 to 2033
TABLE 263: South Africa Market Value (US$ Mn), By Application 2018 to 2022
TABLE 264: South Africa Market Value (US$ Mn), By Application 2023 to 2033
TABLE 265: Nigeria Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 266: Nigeria Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 267: Nigeria Market Value (US$ Mn), By End User 2018 to 2022
TABLE 268: Nigeria Market Value (US$ Mn), By End User 2023 to 2033
TABLE 269: Nigeria Market Value (US$ Mn), By Application 2018 to 2022
TABLE 270: Nigeria Market Value (US$ Mn), By Application 2023 to 2033
TABLE 271: Israel Market Value (US$ Mn), By Product Type 2018 to 2022
TABLE 272: Israel Market Value (US$ Mn), By Product Type 2023 to 2033
TABLE 273: Israel Market Value (US$ Mn), By End User 2018 to 2022
TABLE 274: Israel Market Value (US$ Mn), By End User 2023 to 2033
TABLE 275: Israel Market Value (US$ Mn), By Application 2018 to 2022
TABLE 276: Israel Market Value (US$ Mn), By Application 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1: Global Market Value (US$ Mn), 2018 to 2022
FIG. 2: Global Market Value (US$ Mn) Forecast, 2023 to 2033
FIG. 3: Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2033
FIG. 4: Global Immunotherapy Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 5: Global Immunotherapy Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 6: Global Immunotherapy Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 7: Global Ion Channel Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 8: Global Ion Channel Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 9: Global Ion Channel Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 10: Global GPCR Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 11: Global GPCR Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 12: Global GPCR Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 13: Global Cell Signaling Pathway Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 14: Global Cell Signaling Pathway Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 15: Global Cell Signaling Pathway Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 16: Global Gene Knockout Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 17: Global Gene Knockout Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 18: Global Gene Knockout Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 19: Global Cancer Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 20: Global Cancer Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 21: Global Cancer Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 22: Global Other Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 23: Global Other Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 24: Global Other Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 25: Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 26: Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 27: Global Biopharmaceutical Companies Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 28: Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 29: Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 30: Global Contract Research Organizations (CROs) Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 31: Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 32: Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 33: Global Academic & Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 34: Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 35: Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 36: Global Forensic Science Laboratories Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 37: Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 38: Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 39: Global Food & Beverage Companies Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 40: Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 41: Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 42: Global Diagnostic Centers Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 43: Global Others Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 44: Global Others Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 45: Global Others Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 46: Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 47: Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 48: Global Drug Discovery & Development Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 49: Global Basic Research Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 50: Global Basic Research Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 51: Global Basic Research Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 52: Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 53: Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 54: Global Toxicity Screening Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 55: Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 56: Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 57: Global Biopharmaceutical Production Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 58: Global Drug Screening Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 59: Global Drug Screening Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 60: Global Drug Screening Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 61: Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 62: Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 63: Global Tissue Engineering Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 64: Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2018 to 2022
FIG. 65: Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2023 to 2033
FIG. 66: Global Forensic Testing Segment Y-o-Y Growth Rate, By Region, 2015 to 2033
FIG. 67: North America Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 68: North America Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 69: North America Market Value (US$ Mn), By End User 2018 to 2022
FIG. 70: North America Market Value (US$ Mn), By End User 2023 to 2033
FIG. 71: North America Market Value (US$ Mn), By Application 2018 to 2022
FIG. 72: North America Market Value (US$ Mn), By Application 2023 to 2033
FIG. 73: Latin America Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 74: Latin America Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 75: Latin America Market Value (US$ Mn), By End User 2018 to 2022
FIG. 76: Latin America Market Value (US$ Mn), By End User 2023 to 2033
FIG. 77: Latin America Market Value (US$ Mn), By Application 2018 to 2022
FIG. 78: Latin America Market Value (US$ Mn), By Application 2023 to 2033
FIG. 79: Europe Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 80: Europe Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 81: Europe Market Value (US$ Mn), By End User 2018 to 2022
FIG. 82: Europe Market Value (US$ Mn), By End User 2023 to 2033
FIG. 83: Europe Market Value (US$ Mn), By Application 2018 to 2022
FIG. 84: Europe Market Value (US$ Mn), By Application 2023 to 2033
FIG. 85: Japan Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 86: Japan Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 87: Japan Market Value (US$ Mn), By End User 2018 to 2022
FIG. 88: Japan Market Value (US$ Mn), By End User 2023 to 2033
FIG. 89: Japan Market Value (US$ Mn), By Application 2018 to 2022
FIG. 90: Japan Market Value (US$ Mn), By Application 2023 to 2033
FIG. 91: APEJ Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 92: APEJ Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 93: APEJ Market Value (US$ Mn), By End User 2018 to 2022
FIG. 94: APEJ Market Value (US$ Mn), By End User 2023 to 2033
FIG. 95: APEJ Market Value (US$ Mn), By Application 2018 to 2022
FIG. 96: APEJ Market Value (US$ Mn), By Application 2023 to 2033
FIG. 97: MEA Market Value (US$ Mn), By Product Type 2018 to 2022
FIG. 98: MEA Market Value (US$ Mn), By Product Type 2023 to 2033
FIG. 99: MEA Market Value (US$ Mn), By End User 2018 to 2022
FIG. 100: MEA Market Value (US$ Mn), By End User 2023 to 2033
FIG. 101: MEA Market Value (US$ Mn), By Application 2018 to 2022
FIG. 102: MEA Market Value (US$ Mn), By Application 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the cell line development market worth?
The global cell line development market is valued at US$ 4.97 billion in 2023.
What is the estimated size of the industry for 2033?
Revenue of the cell line development industry is set to reach US$ 8.2 billion by 2033-end.
What is the growth rate of the cell line development market?
Worldwide cell line development demand is predicted to rise at 5.1% CAGR from 2023 to 2033.
What is the market share of the United States?
Cell line development demand in the United States accounts for more than 90% share of the North American market.
Who are the prime companies in the global market for cell line development?
Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd., Corning Incorporated, Selexis SA, Sigma-Aldrich Corporation, and Sartorius AG are key companies in this market.
Cell Line Development Market